Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

about

Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

Item

http://www.wikidata.org/entity/Q55069738

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Determination of binding affin ...... ne receptors in breast cancer.

@en

Determination of binding affin ...... ne receptors in breast cancer.

@nl

type

Item

label

Determination of binding affin ...... ne receptors in breast cancer.

@en

Determination of binding affin ...... ne receptors in breast cancer.

@nl

prefLabel

Determination of binding affin ...... ne receptors in breast cancer.

@en

Determination of binding affin ...... ne receptors in breast cancer.

@nl

P1476

Determination of binding affin ...... ne receptors in breast cancer.

@en

P2093

Amy M Fowler

http://www.w3.org/2001/XMLSchema#string

Ciara J Michel

http://www.w3.org/2001/XMLSchema#string

Kelley Salem

http://www.w3.org/2001/XMLSchema#string

Kyle C Kloepping

http://www.w3.org/2001/XMLSchema#string

Yongjun Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer cell lines: friend or foe?

Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.

Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.

Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

Establishment and characterization of a cell line of human breast carcinoma origin.

Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.

Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

P304

119-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manoj Kumar

P577

2018-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29755845

http://www.w3.org/2001/XMLSchema#string

P932

5944827

http://www.w3.org/2001/XMLSchema#string